NCT00507832View on ClinicalTrials.gov

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2009

Conditions

Prurigo Nodularis

Interventions

DRUG

Pimecrolimus

twice daily topical

DRUG

Hydrocortisone

twice daily topical

DRUG

Pimecrolimus

topical application as a cream twice daily

Trial Locations (1)

48149

Department of Dermtology, University of Münster, Münster

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University Hospital Muenster

OTHER